Clinical Trials Browser

Phase NA × Interventional × Amyloidosis × Clear all

NCT02641145 2025-11-14

MICA

Phase NA Recruiting

Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Cardiomyopathies

NCT04392960 2025-05-07

Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis

Phase NA Recruiting

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT05260203 2024-11-06

MargheRITA

Phase NA Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT06376214 2024-04-19

Daratumumab for Patients With Light Chain Amyloidosis

Phase NA Recruiting

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT02158052 2022-12-13

Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

Phase NA Completed

2 enrolled 10 charts

Amyloidosis, Multiple Myeloma

NCT01383759 2020-04-07

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

Phase NA Completed

20 enrolled 16 charts

Noninsulin-dependent diabetes mellitus with deafness, Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT03779815 2019-04-18

PET

Phase NA Completed

Amyloidosis, Multiple Myeloma

NCT00890552 2017-03-22

A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis

Phase NA Completed

25 enrolled 12 charts

Other hematologic neoplasmPlasma cell

Amyloidosis, Leukemia